SCHEMBL25832010

SCHEMBL25832010

COc1ccc2c(c1)[nH]c1c(C(=O)O)nccc12

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 15/20 0.81
BCHE P06276 3/20 0.81
ACHE P22303 2/20 0.81
MAOA P21397 3/20 0.65
GSK3B P49841 2/20 0.65
KDM4E B2RXH2 1/20 0.65
DYRK3 O43781 1/20 0.65
CCNT1 O60563 1/20 0.65
CCNB2 O95067 1/20 0.65
ALDH1A1 P00352 1/20 0.65
CYP1A2 P05177 1/20 0.65
CDK1 P06493 1/20 0.65
CYP3A4 P08684 1/20 0.65
ADRA2A P08913 1/20 0.65
CYP2D6 P10635 1/20 0.65
CCNB1 P14635 1/20 0.65
HPGD P15428 1/20 0.65
ADRA2B P18089 1/20 0.65
ADRA2C P18825 1/20 0.65
CCNA2 P20248 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30601059 1.00 DYRK1A (0.81) DYRK1ABCHEACHEMAOAGSK3B
Arenarine C SCHEMBL30199121 0.90 DYRK1A (1.00) DYRK1ABCHEACHEMAOAGSK3B
Arenarine C SCHEMBL645800 0.90 DYRK1A (1.00) DYRK1ABCHEACHEMAOAGSK3B
SCHEMBL25832011 0.88 DYRK1A (0.79) DYRK1ABCHEACHEMAOAGSK3B
SCHEMBL30199348 0.88 DYRK1A (0.79) DYRK1ABCHEACHEMAOAGSK3B
Harmic Acid Methyl Ester SCHEMBL25294090 0.88 DYRK1A (0.79) DYRK1ABCHEACHEMAOAGSK3B
Trigonostemine B SCHEMBL30492900 0.82 DYRK1A (0.69) DYRK1ABCHEACHEMAOAGSK3B
SCHEMBL3182013 0.82 DYRK1A (0.55) DYRK1ABCHEACHEMAOAGSK3B
Harmine SCHEMBL30785200 0.80 DYRK1A (0.79) DYRK1ABCHEACHEMAOAGSK3B
SCHEMBL29237544 0.80 CCNB2 (0.61) DYRK1ABCHEACHEMAOAGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023130076-A2 TARGETS AND PATHWAYS FOR THE PRODUCTION OF ALKALOIDAL COMPOUNDS Empyrean Neuroscience, Inc. (US) 2023-07-06 WO disclosed
WO-2023130078-A2 GENETICALLY MODIFIED MYCELIUM FOR PRODUCING PSYCHOTROPIC ALKALOIDS Empyrean Neuroscience, Inc. (US) 2023-07-06 WO disclosed
WO-2023130075-A2 GENETICALLY MODIFIED ORGANISMS FOR PRODUCING PSYCHOTROPIC ALKALOIDS Empyrean Neuroscience, Inc. (US) 2023-07-06 WO disclosed